Codexis to Participate in Upcoming Healthcare Conferences
REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in four upcoming investor conferences.
The Jefferies London Healthcare Conference (London, UK)
- Tuesday, November 14, 2023, at 1:00 pm GMT, management will participate in a fireside chat
The Stifel 2023 Healthcare Conference (New York, NY)
- Tuesday, November 14, 2023, at 9:10 am ET, management will participate in a fireside chat
The Stephens Annual Investment Conference (Nashville, TN)
- Wednesday, November 15, 2023, at 9:00 am CT, management will participate in a fireside chat
The 14th Annual Craig-Hallum Alpha Select Conference (New York, NY)
- Thursday, November 16, 2023, management will host 1x1 investor meetings
Live webcasts of each fireside chat will be available on the Investor Relations section of the Company’s website, https://ir.codexis.com. A replay of each fireside chat will be archived for 90 days following the presentation date.
About Codexis
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com
Media Contact
Lauren Musto
(781) 572-1147
media@codexis.com
Released October 31, 2023